Does Medical Marijuana Cut Down on Prescription Drug Use?

The rise in the number of states allowing marijuana for medical use seems to be having an unexpected benefit: It has led to fewer drug prescriptions being filled, especially meds used to treat pain.

W. David Bradford, PhD, of the Department of Public Administration and Policy at the University of Georgia and his daughter, Ashley C. Bradford, a graduate student in the department, made their conclusion based on prescriptions filled under the Medicare Prescription Drug Plan (Part D) between 2010 to 2013.

In 2013, 17 states and the District of Columbia allowed cannabis to be prescribed for medicinal purposes. Now, it’s 25 states.

The pair focused on scripts written in these states that could potentially be substituted for medical marijuana instead, to treat conditions such as glaucoma, nausea, pain, seizures, depression and anxiety.

Fewer prescriptions were written for most of the conditions: A drop of 1,826 daily doses in the pain category and 265 in the depression category, for example, the researchers reported in Health Affairs.

However, the number of daily doses for glaucoma medication increased by 35. The researchers explained that even though marijuana can produce a reduction in eye pressure, the effect only lasts about an hour, and expecting patients to take marijuana throughout the day is considered “unrealistic.”

The Part D program also saw a financial benefit from states with medical marijuana laws since fewer prescriptions were filled. The Bradfords estimated those savings to be $165.2 million in 2013. In addition, the results suggest that if all 50 states had medical marijuana laws on the books, the overall savings to Medicare would have been about $468 million.

While medical marijuana may appear to be a panacea for many conditions, it is important to note that there is a potential for abuse. Many states now require medical marijuana patients to have an established relationship with their doctor and a physical exam in order to receive cannabis, an effort to curb the use of so-called “pot doctors.”

However, compared to traditional prescription medications, marijuana’s side effects appear to be more mild, one factor in why people turn to cannabis for relief.


Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Breaking News – EpiPen Malfunction

Breaking News – EpiPen Malfunction

Just released from the FDA – Pfizer has informed the FDA that they are aware of several continuing problems that people are having using the EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors and generic versions. Some of the problems are from user error and some from EpiPen malfunction. Here are…

ACE Inhibitors in the Time of Coronavirus

ACE Inhibitors in the Time of Coronavirus

Are you worried about ACE inhibitors and coronavirus? You may be hearing that one of the entry methods for the coronavirus in humans is by attaching to the ACE-2 enzyme. This has raised alarms among those with heart disease who use ACE inhibitors (with names ending in -pril, such as…

  • Advertisement